Your browser doesn't support javascript.
loading
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard, Christa; Jacobs, Bart C; Lingsma, Hester F; Steyerberg, Ewout W; van den Berg, Bianca; Doets, Alexandra Y; Leonhard, Sonja E; Verboon, Christine; Huizinga, Ruth; Drenthen, Judith; Arends, Samuel; Budde, Ilona Kleine; Kleyweg, Ruud P; Kuitwaard, Krista; van der Meulen, Marjon F G; Samijn, Johnny P A; Vermeij, Frederique H; Kuks, Jan B M; van Dijk, Gert W; Wirtz, Paul W; Eftimov, Filip; van der Kooi, Anneke J; Garssen, Marcel P J; Gijsbers, Cees J; de Rijk, Maarten C; Visser, Leo H; Blom, Roderik J; Linssen, Wim H J P; van der Kooi, Elly L; Verschuuren, Jan J G M; van Koningsveld, Rinske; Dieks, Rita J G; Gilhuis, H Job; Jellema, Korné; van der Ree, Taco C; Bienfait, Henriette M E; Faber, Catharina G; Lovenich, Harry; van Engelen, Baziel G M; Groen, Rutger J; Merkies, Ingemar S J; van Oosten, Bob W; van der Pol, W Ludo; van der Meulen, Willem D M; Badrising, Umesh A; Stevens, Martijn; Breukelman, Albert-Jan J; Zwetsloot, Casper P; van der Graaff, Maaike M; Wohlgemuth, Marielle.
Afiliación
  • Walgaard C; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Jacobs BC; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands; Department of Immunology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Lingsma HF; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Steyerberg EW; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.
  • van den Berg B; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands; Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands.
  • Doets AY; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Leonhard SE; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Verboon C; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Huizinga R; Department of Immunology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Drenthen J; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Arends S; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Budde IK; The Medical Department, Sanquin Plasma Products, Amsterdam, Netherlands.
  • Kleyweg RP; Department of Neurology, Albert Schweitzer Hospital, Dordrecht, Netherlands.
  • Kuitwaard K; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands; Department of Neurology, Albert Schweitzer Hospital, Dordrecht, Netherlands.
  • van der Meulen MFG; Department of Neurology, Sint Antonius Hospital, Nieuwegein, Netherlands.
  • Samijn JPA; Department of Neurology, Maasstad Hospital, Rotterdam, Netherlands.
  • Vermeij FH; Department of Neurology, Franciscus en Vlietland Hospital, Rotterdam, Netherlands.
  • Kuks JBM; Department of Neurology, University Medical Center Groningen, Groningen, Netherlands.
  • van Dijk GW; Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands.
  • Wirtz PW; Department of Neurology, Haga Hospital, Den Haag, Netherlands.
  • Eftimov F; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • van der Kooi AJ; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Garssen MPJ; Department of Neurology, Jeroen Bosch hospital, Den Bosch, Netherlands.
  • Gijsbers CJ; Department of Neurology, Franciscus en Vlietland Hospital, Rotterdam, Netherlands.
  • de Rijk MC; Department of Neurology, Catharina Hospital, Eindhoven, Netherlands.
  • Visser LH; Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands.
  • Blom RJ; Department of Neurology, Diakonessenhuis, Utrecht, Netherlands.
  • Linssen WHJP; Department of Neurology, Onze Lieve Vrouwen Gasthuis-West, Amsterdam, Netherlands; Zaans Medical Center, Zaandam, Netherlands.
  • van der Kooi EL; Department of Neurology, Leeuwarden Medical Center, Leeuwarden, Netherlands.
  • Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
  • van Koningsveld R; Department of Neurology, Elkerliek Hospital, Helmond, Netherlands.
  • Dieks RJG; Department of Neurology, Röpke-Zweers Hospital, Hardenberg, Netherlands.
  • Gilhuis HJ; Department of Neurology, Reinier de Graaf Hospital, Delft, Netherlands.
  • Jellema K; Department of Neurology, Haaglanden Medical Center, Den Haag, Netherlands.
  • van der Ree TC; Department of Neurology, Dijklander hospital, Hoorn, Netherlands.
  • Bienfait HME; Department of Neurology, Spaarne Gasthuis, Haarlem, Netherlands.
  • Faber CG; Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Lovenich H; Department of Neurology, St Jans Hospital, Weert, Netherlands.
  • van Engelen BGM; Department of Neurology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Groen RJ; Department of Neurology, Haaglanden Medical Center, Den Haag, Netherlands.
  • Merkies ISJ; Department of Neurology, Spaarne Gasthuis, Haarlem, Netherlands; Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands.
  • van Oosten BW; Department of Neurology, Amsterdam University Medical Centers, VUmc, Amsterdam, Netherlands.
  • van der Pol WL; Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands.
  • van der Meulen WDM; Department of Neurology, Rode Kruis Hospital, Beverwijk, Netherlands.
  • Badrising UA; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; Department of Neurology, van Weel-Bethesda Hospital, Dirksland, Netherlands.
  • Stevens M; Department of Neurology, Tergooi Hospitals, Blaricum, Netherlands.
  • Breukelman AJ; Department of Neurology, ZorgSaam Hospital, Terneuzen, Netherlands.
  • Zwetsloot CP; Department of Neurology, Dijklander Hospital, Purmerend, Netherlands.
  • van der Graaff MM; Department of Neurology, BovenIJ Hospital, Amsterdam, Netherlands.
  • Wohlgemuth M; Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands.
Lancet Neurol ; 20(4): 275-283, 2021 04.
Article en En | MEDLINE | ID: mdl-33743237
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulinas Intravenosas / Síndrome de Guillain-Barré Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulinas Intravenosas / Síndrome de Guillain-Barré Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos